Ozempic Nation: Paradigm Shift or Public Health Mirage?

Ozempic Nation Paradigm Shift or Public Health Mirage Review Abstract The emergence of glucagon-like peptide-1 (GLP-1) receptor agonists and related incretin-based therapies has transformed the management of obesity and type 2 diabetes mellitus. Semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, initiated a major shift in

Breaking Free: How Mounjaro Helps Smokers Quit Without Nicotine Patches

Breaking Free How Mounjaro Helps Smokers Quit Without Nicotine Patches   Check back later for a possible video summary. Videos are created for most articles.     Introduction Breaking Free: How Mounjaro Helps Smokers Quit Without Nicotine Patches In 2021, almost 46 million adults in the United States reported using nicotine products, and research on the

Ozempic Nation: Paradigm Shift or Public Health Mirage?